Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
Authors:
Open Access
- 23 June 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (13) , 5344-5354
Abstract
A series of 6-hetaryloxy benzoxaborole compounds was designed and synthesized for a structure–activity relationship (SAR) investigation to assess the changes in antimalarial activity which result from 6-aryloxy structural variation, substituent modification on the pyrazine ring, and optimization of the side chain ester group. This SAR study discovered highly potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles (9, 27–34) with IC50s = 0.2–22 nM against cultured Plasmodium falciparum W2 and 3D7 strains. Compound 9 also demonstrated excellent in vivo efficacy against P. berghei in infected mice (ED90 = 7.0 mg/kg).Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI095324)
- Medicines for Malaria Venture
This publication has 24 references indexed in Scilit:
- The interplay between drug resistance and fitness in malaria parasitesMolecular Microbiology, 2013
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaProceedings of the National Academy of Sciences, 2011
- Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agentsBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters, 2010
- Spiroindolones, a Potent Compound Class for the Treatment of MalariaScience, 2010
- Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory applicationBioorganic & Medicinal Chemistry Letters, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitisBioorganic & Medicinal Chemistry Letters, 2009
- An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing SiteScience, 2007
- Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the Potential Treatment of OnychomycosisJournal of Medicinal Chemistry, 2006